Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
169,096,637
-
Total 13F shares
-
37,768,617
-
Share change
-
+100,502
-
Total reported value
-
$569,884,178
-
Put/Call ratio
-
0%
-
Price per share
-
$15.10
-
Number of holders
-
108
-
Value change
-
-$2,745,916
-
Number of buys
-
49
-
Number of sells
-
60
Institutional Holders of CytomX Therapeutics, Inc. - COMMON STOCK (CTMX) as of Q4 2018
As of 31 Dec 2018,
CytomX Therapeutics, Inc. - COMMON STOCK (CTMX) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,768,617 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Point72 Asset Management, L.P., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.